These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7689973

  • 1. Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.
    Assié MB, Sleight AJ, Koek W.
    Eur J Pharmacol; 1993 Jun 24; 237(2-3):183-9. PubMed ID: 7689973
    [Abstract] [Full Text] [Related]

  • 2. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
    Assié MB, Consul-Denjean N, Koek W, Newman-Tancredi A.
    Pharmacology; 2005 Oct 24; 75(2):63-8. PubMed ID: 16020947
    [Abstract] [Full Text] [Related]

  • 3. Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors.
    Sleight AJ, Koek W, Bigg DC.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):407-10. PubMed ID: 7691623
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun 20; 329(4):333-43. PubMed ID: 2863760
    [Abstract] [Full Text] [Related]

  • 5. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE, Janssen PM, Megens AA, Schotte A.
    J Clin Psychiatry; 1994 May 20; 55 Suppl():5-12. PubMed ID: 7520908
    [Abstract] [Full Text] [Related]

  • 6. Autoradiography of dopamine D2 receptors using [3H]YM-09151-2.
    Cox RF, Waszczak BL.
    Eur J Pharmacol; 1991 Jun 18; 199(1):103-6. PubMed ID: 1680055
    [Abstract] [Full Text] [Related]

  • 7. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA, DiCarlo JJ, Zhang Y, Thompson P, Meltzer HY.
    J Pharmacol Exp Ther; 1993 Sep 18; 266(3):1374-84. PubMed ID: 8103793
    [Abstract] [Full Text] [Related]

  • 8. In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
    Sumiyoshi T, Kido H, Sakamoto H, Urasaki K, Suzuki K, Yamaguchi N, Mori H, Shiba K, Yokogawa K.
    Pharmacol Biochem Behav; 1994 Mar 18; 47(3):553-7. PubMed ID: 7516078
    [Abstract] [Full Text] [Related]

  • 9. Characterization of [3H]clozapine binding sites in rat brain.
    Kusumi I, Matsubara S, Takahashi Y, Ishikane T, Koyama T.
    J Neural Transm Gen Sect; 1995 Mar 18; 101(1-3):51-64. PubMed ID: 8695057
    [Abstract] [Full Text] [Related]

  • 10. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
    Hatano K, Ishiwata K, Kawashima K, Hatazawa J, Itoh M, Ido T.
    J Nucl Med; 1989 Apr 18; 30(4):515-22. PubMed ID: 2567779
    [Abstract] [Full Text] [Related]

  • 11. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 18; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 12. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
    Hall H, Halldin C, Nyberg S, Farde L, Sedvall G.
    Eur Neuropsychopharmacol; 1995 Mar 18; 5(1):19-25. PubMed ID: 7542051
    [Abstract] [Full Text] [Related]

  • 13. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A, Jerning E, Mohell N.
    Eur J Pharmacol; 1996 May 06; 303(1-2):123-8. PubMed ID: 8804920
    [Abstract] [Full Text] [Related]

  • 14. Clozapine occupies high levels of dopamine D2 receptors.
    Seeman P, Kapur S.
    Life Sci; 1997 May 06; 60(12):PL 207-16. PubMed ID: 9061054
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Leysen JE, Janssen PM, Gommeren W, Wynants J, Pauwels PJ, Janssen PA.
    Mol Pharmacol; 1992 Mar 06; 41(3):494-508. PubMed ID: 1372084
    [Abstract] [Full Text] [Related]

  • 16. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
    Malmberg A, Jackson DM, Eriksson A, Mohell N.
    Mol Pharmacol; 1993 May 06; 43(5):749-54. PubMed ID: 8099194
    [Abstract] [Full Text] [Related]

  • 17. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A, Janssen PF, Megens AA, Leysen JE.
    Brain Res; 1993 Dec 24; 631(2):191-202. PubMed ID: 7510574
    [Abstract] [Full Text] [Related]

  • 18. Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.
    Altar CA, Wasley AM, Neale RF, Stone GA.
    Brain Res Bull; 1986 Apr 24; 16(4):517-25. PubMed ID: 2872945
    [Abstract] [Full Text] [Related]

  • 19. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography.
    Seeman P, Guan HC, Civelli O, Van Tol HH, Sunahara RK, Niznik HB.
    Eur J Pharmacol; 1992 Oct 01; 227(2):139-46. PubMed ID: 1358662
    [Abstract] [Full Text] [Related]

  • 20. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
    Luedtke RR, Freeman RA, Boundy VA, Martin MW, Huang Y, Mach RH.
    Synapse; 2000 Dec 15; 38(4):438-49. PubMed ID: 11044891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.